Sanofi (TSX:SNY)

Market Cap	159.57B -15.3%
Revenue (ttm)	75.21B +5.5%
Net Income	12.58B +40.5%
EPS	10.31 +44.2%
Shares Out	n/a
PE Ratio	12.69
Forward PE	9.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111,636
Average Volume	6,275
Open	20.97
Previous Close	n/a
Day's Range	20.96 - 21.02
52-Week Range	20.10 - 22.57
Beta	n/a
RSI	44.12
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: SNY

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR